The development of systemic sclerosis classification criteria
Systemic sclerosis (SSc) is a rare connective tissue disorder whose aetiology remains obscure, although environmental and genetic influences are likely to play a role. Disease registries have contributed to enhancing our understanding of this debilitating illness, but without sensitive, specific, an...
Gespeichert in:
Veröffentlicht in: | Clinical rheumatology 2007-09, Vol.26 (9), p.1401-1409 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1409 |
---|---|
container_issue | 9 |
container_start_page | 1401 |
container_title | Clinical rheumatology |
container_volume | 26 |
creator | Walker, Jennifer G Pope, Janet Baron, Murray Leclercq, Sharon Hudson, Marie Taillefer, Suzanne Edworthy, Steven M Nadashkevich, Oleg Fritzler, Marvin J |
description | Systemic sclerosis (SSc) is a rare connective tissue disorder whose aetiology remains obscure, although environmental and genetic influences are likely to play a role. Disease registries have contributed to enhancing our understanding of this debilitating illness, but without sensitive, specific, and extensively validated classification criteria, accurate comparison between registries and the identification of patients suitable for clinical trials can be problematic. The American College of Rheumatology (ACR) criteria, published in 1980, have become outdated as our understanding of disease specific autoantibodies and nailfold capillaroscopy has improved. In addition, the sensitivity of the ACR criteria is low with respect to limited SSc. Although subsequent classification systems have been proposed, none has gained universal approval. The two- versus three-subset disease model remains a point of debate. Newly derived criteria are likely to draw upon the older classification systems as well as incorporating up-to-date diagnostic techniques and biomarkers. Validation will be critical before their use becomes widespread. |
doi_str_mv | 10.1007/s10067-007-0537-x |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_journals_881276378</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2417756881</sourcerecordid><originalsourceid>FETCH-LOGICAL-p135t-839b8ffab58438e22ae0bb5a698c88584cbeda973002b30e6a9ca1999e1765733</originalsourceid><addsrcrecordid>eNo1T01LxDAUDKK46-oP8CLFezTJa5uXgwdZ_IIFL-u5JOkrZumXSVfcf2_B9TLzGIaZN4xdS3EnhdD3acZS8_nkogDNf07YUuaQc2Nyc8qWQmvBQRpcsIuUdkIIhUaes4XUCgulYMketp-U1fRN7TB21E_Z0GTpkCbqgs-SbykOKaTMtzal0ARvpzD0mY9hohjsJTtrbJvo6sgr9vH8tF2_8s37y9v6ccNHCcXEEYzDprGuwByQlLIknCtsadAjzqJ3VFujYX7QgaDSGm-lMYakLgsNsGK3f7ljHL72lKZqN-xjP1dWiFLpEjTOppujae86qqsxhs7GQ_U_Fn4BJf9WqQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>881276378</pqid></control><display><type>article</type><title>The development of systemic sclerosis classification criteria</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Walker, Jennifer G ; Pope, Janet ; Baron, Murray ; Leclercq, Sharon ; Hudson, Marie ; Taillefer, Suzanne ; Edworthy, Steven M ; Nadashkevich, Oleg ; Fritzler, Marvin J</creator><creatorcontrib>Walker, Jennifer G ; Pope, Janet ; Baron, Murray ; Leclercq, Sharon ; Hudson, Marie ; Taillefer, Suzanne ; Edworthy, Steven M ; Nadashkevich, Oleg ; Fritzler, Marvin J</creatorcontrib><description>Systemic sclerosis (SSc) is a rare connective tissue disorder whose aetiology remains obscure, although environmental and genetic influences are likely to play a role. Disease registries have contributed to enhancing our understanding of this debilitating illness, but without sensitive, specific, and extensively validated classification criteria, accurate comparison between registries and the identification of patients suitable for clinical trials can be problematic. The American College of Rheumatology (ACR) criteria, published in 1980, have become outdated as our understanding of disease specific autoantibodies and nailfold capillaroscopy has improved. In addition, the sensitivity of the ACR criteria is low with respect to limited SSc. Although subsequent classification systems have been proposed, none has gained universal approval. The two- versus three-subset disease model remains a point of debate. Newly derived criteria are likely to draw upon the older classification systems as well as incorporating up-to-date diagnostic techniques and biomarkers. Validation will be critical before their use becomes widespread.</description><identifier>ISSN: 0770-3198</identifier><identifier>EISSN: 1434-9949</identifier><identifier>DOI: 10.1007/s10067-007-0537-x</identifier><identifier>PMID: 17285223</identifier><language>eng</language><publisher>Germany: Springer Nature B.V</publisher><subject>Autoantibodies ; Autoantibodies - immunology ; Biomarkers - analysis ; Classification ; Classification systems ; Clinical trials ; Connective tissue diseases ; Humans ; Microscopic Angioscopy ; Rheumatology ; Scleroderma ; Scleroderma, Systemic - classification ; Scleroderma, Systemic - diagnosis ; Systemic sclerosis</subject><ispartof>Clinical rheumatology, 2007-09, Vol.26 (9), p.1401-1409</ispartof><rights>Clinical Rheumatology 2007.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786,27933,27934</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17285223$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Walker, Jennifer G</creatorcontrib><creatorcontrib>Pope, Janet</creatorcontrib><creatorcontrib>Baron, Murray</creatorcontrib><creatorcontrib>Leclercq, Sharon</creatorcontrib><creatorcontrib>Hudson, Marie</creatorcontrib><creatorcontrib>Taillefer, Suzanne</creatorcontrib><creatorcontrib>Edworthy, Steven M</creatorcontrib><creatorcontrib>Nadashkevich, Oleg</creatorcontrib><creatorcontrib>Fritzler, Marvin J</creatorcontrib><title>The development of systemic sclerosis classification criteria</title><title>Clinical rheumatology</title><addtitle>Clin Rheumatol</addtitle><description>Systemic sclerosis (SSc) is a rare connective tissue disorder whose aetiology remains obscure, although environmental and genetic influences are likely to play a role. Disease registries have contributed to enhancing our understanding of this debilitating illness, but without sensitive, specific, and extensively validated classification criteria, accurate comparison between registries and the identification of patients suitable for clinical trials can be problematic. The American College of Rheumatology (ACR) criteria, published in 1980, have become outdated as our understanding of disease specific autoantibodies and nailfold capillaroscopy has improved. In addition, the sensitivity of the ACR criteria is low with respect to limited SSc. Although subsequent classification systems have been proposed, none has gained universal approval. The two- versus three-subset disease model remains a point of debate. Newly derived criteria are likely to draw upon the older classification systems as well as incorporating up-to-date diagnostic techniques and biomarkers. Validation will be critical before their use becomes widespread.</description><subject>Autoantibodies</subject><subject>Autoantibodies - immunology</subject><subject>Biomarkers - analysis</subject><subject>Classification</subject><subject>Classification systems</subject><subject>Clinical trials</subject><subject>Connective tissue diseases</subject><subject>Humans</subject><subject>Microscopic Angioscopy</subject><subject>Rheumatology</subject><subject>Scleroderma</subject><subject>Scleroderma, Systemic - classification</subject><subject>Scleroderma, Systemic - diagnosis</subject><subject>Systemic sclerosis</subject><issn>0770-3198</issn><issn>1434-9949</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNo1T01LxDAUDKK46-oP8CLFezTJa5uXgwdZ_IIFL-u5JOkrZumXSVfcf2_B9TLzGIaZN4xdS3EnhdD3acZS8_nkogDNf07YUuaQc2Nyc8qWQmvBQRpcsIuUdkIIhUaes4XUCgulYMketp-U1fRN7TB21E_Z0GTpkCbqgs-SbykOKaTMtzal0ARvpzD0mY9hohjsJTtrbJvo6sgr9vH8tF2_8s37y9v6ccNHCcXEEYzDprGuwByQlLIknCtsadAjzqJ3VFujYX7QgaDSGm-lMYakLgsNsGK3f7ljHL72lKZqN-xjP1dWiFLpEjTOppujae86qqsxhs7GQ_U_Fn4BJf9WqQ</recordid><startdate>200709</startdate><enddate>200709</enddate><creator>Walker, Jennifer G</creator><creator>Pope, Janet</creator><creator>Baron, Murray</creator><creator>Leclercq, Sharon</creator><creator>Hudson, Marie</creator><creator>Taillefer, Suzanne</creator><creator>Edworthy, Steven M</creator><creator>Nadashkevich, Oleg</creator><creator>Fritzler, Marvin J</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>200709</creationdate><title>The development of systemic sclerosis classification criteria</title><author>Walker, Jennifer G ; Pope, Janet ; Baron, Murray ; Leclercq, Sharon ; Hudson, Marie ; Taillefer, Suzanne ; Edworthy, Steven M ; Nadashkevich, Oleg ; Fritzler, Marvin J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p135t-839b8ffab58438e22ae0bb5a698c88584cbeda973002b30e6a9ca1999e1765733</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Autoantibodies</topic><topic>Autoantibodies - immunology</topic><topic>Biomarkers - analysis</topic><topic>Classification</topic><topic>Classification systems</topic><topic>Clinical trials</topic><topic>Connective tissue diseases</topic><topic>Humans</topic><topic>Microscopic Angioscopy</topic><topic>Rheumatology</topic><topic>Scleroderma</topic><topic>Scleroderma, Systemic - classification</topic><topic>Scleroderma, Systemic - diagnosis</topic><topic>Systemic sclerosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Walker, Jennifer G</creatorcontrib><creatorcontrib>Pope, Janet</creatorcontrib><creatorcontrib>Baron, Murray</creatorcontrib><creatorcontrib>Leclercq, Sharon</creatorcontrib><creatorcontrib>Hudson, Marie</creatorcontrib><creatorcontrib>Taillefer, Suzanne</creatorcontrib><creatorcontrib>Edworthy, Steven M</creatorcontrib><creatorcontrib>Nadashkevich, Oleg</creatorcontrib><creatorcontrib>Fritzler, Marvin J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Clinical rheumatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Walker, Jennifer G</au><au>Pope, Janet</au><au>Baron, Murray</au><au>Leclercq, Sharon</au><au>Hudson, Marie</au><au>Taillefer, Suzanne</au><au>Edworthy, Steven M</au><au>Nadashkevich, Oleg</au><au>Fritzler, Marvin J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The development of systemic sclerosis classification criteria</atitle><jtitle>Clinical rheumatology</jtitle><addtitle>Clin Rheumatol</addtitle><date>2007-09</date><risdate>2007</risdate><volume>26</volume><issue>9</issue><spage>1401</spage><epage>1409</epage><pages>1401-1409</pages><issn>0770-3198</issn><eissn>1434-9949</eissn><abstract>Systemic sclerosis (SSc) is a rare connective tissue disorder whose aetiology remains obscure, although environmental and genetic influences are likely to play a role. Disease registries have contributed to enhancing our understanding of this debilitating illness, but without sensitive, specific, and extensively validated classification criteria, accurate comparison between registries and the identification of patients suitable for clinical trials can be problematic. The American College of Rheumatology (ACR) criteria, published in 1980, have become outdated as our understanding of disease specific autoantibodies and nailfold capillaroscopy has improved. In addition, the sensitivity of the ACR criteria is low with respect to limited SSc. Although subsequent classification systems have been proposed, none has gained universal approval. The two- versus three-subset disease model remains a point of debate. Newly derived criteria are likely to draw upon the older classification systems as well as incorporating up-to-date diagnostic techniques and biomarkers. Validation will be critical before their use becomes widespread.</abstract><cop>Germany</cop><pub>Springer Nature B.V</pub><pmid>17285223</pmid><doi>10.1007/s10067-007-0537-x</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0770-3198 |
ispartof | Clinical rheumatology, 2007-09, Vol.26 (9), p.1401-1409 |
issn | 0770-3198 1434-9949 |
language | eng |
recordid | cdi_proquest_journals_881276378 |
source | MEDLINE; SpringerNature Journals |
subjects | Autoantibodies Autoantibodies - immunology Biomarkers - analysis Classification Classification systems Clinical trials Connective tissue diseases Humans Microscopic Angioscopy Rheumatology Scleroderma Scleroderma, Systemic - classification Scleroderma, Systemic - diagnosis Systemic sclerosis |
title | The development of systemic sclerosis classification criteria |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-11-30T03%3A58%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20development%20of%20systemic%20sclerosis%20classification%20criteria&rft.jtitle=Clinical%20rheumatology&rft.au=Walker,%20Jennifer%20G&rft.date=2007-09&rft.volume=26&rft.issue=9&rft.spage=1401&rft.epage=1409&rft.pages=1401-1409&rft.issn=0770-3198&rft.eissn=1434-9949&rft_id=info:doi/10.1007/s10067-007-0537-x&rft_dat=%3Cproquest_pubme%3E2417756881%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=881276378&rft_id=info:pmid/17285223&rfr_iscdi=true |